Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review

World J Clin Oncol. 2023 Feb 24;14(2):81-88. doi: 10.5306/wjco.v14.i2.81.

Abstract

Cold colorectal tumors are not likely to trigger a robust immune response and tend to suppress the immune response. There may be three reasons. First, the complex tumor microenvironment of cold colorectal cancer (CRC) leads to tolerance and clearance of immunotherapy. Second, the modification and concealment of tumor-specific targets in cold CRC cause immune escape and immune response interruption. Finally, the difference in number and function of immune cell subsets in patients with cold CRC makes them respond poorly to immunotherapy. Therefore, we can only overcome the challenges in immunotherapy of cold CRC through in-depth research and understanding the changes and mechanisms in the above three aspects of cold CRC.

Keywords: Cold colorectal cancer; Immune cells; Immune targets; Immunotherapy; Tumor microenvironment.

Publication types

  • Review